Streetbeat News

Products Services

CPTN

Cepton's stock is trading lower following the announcement that its tier 1 partner, Koito, has had all outstanding purchase orders related to a series production award cancelled by the OEM, which is re-scoping its ADAS offerings.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 6:39 pm

ALEC

Stifel has upgraded Alector Inc (NASDAQ:ALEC) from Hold to Buy with a new price target of $15, up from $8, citing the high reward potential of AL002, Alector's Alzheimer's disease candidate. The Phase 2 results for AL002 are expected in Q4 2024. Despite the high risk associated with Alzheimer's treatments, Stifel believes the probability of success for AL002 is above average. Alector's stock has risen 16.49% to $8.04 following the upgrade.

Portfolio Pulse from Vandana Singh

December 14, 2023 | 6:29 pm

JPM

JPMorgan Chase & Co (NYSE:JPM) has a cautious outlook for the crypto market in 2024, despite expecting Ethereum to outperform Bitcoin due to an upgrade enhancing scalability. The bank believes the SEC's potential approval of spot Bitcoin ETFs may not significantly boost the market, with the Bitcoin halving event already priced in. JPMorgan also notes tentative venture capital funding resurgence and limited DeFi progress in traditional finance integration.

Portfolio Pulse from Murtuza Merchant

December 14, 2023 | 6:14 pm

TD

TD Bank Group (TD) has entered into a data-access agreement with Plaid to enhance data security for TD customers in North America. This agreement allows secure connection to Plaid's network of over 8,000 apps and services without sharing login credentials. TD's commitment to secure and transparent digital experiences is further evidenced by previous agreements with Finicity, Akoya, and Envestnet | Yodlee, and participation in the Financial Data Exchange (FDX).

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 6:05 pm

ADAUSD

Cardano's (ADA) token has seen a significant increase in value, with a 40% gain in the past week and a 76% increase over the past month. The total value locked (TVL) in Cardano-based DeFi projects has surpassed its March 2022 peak, reaching $430.36 million. The growth is attributed to the performance of lending protocol Indigo and on-chain exchange Minswap, as well as the Djed stablecoin. Analyst Jason Appleton, also known as Crypto Crow, predicts that Cardano could become the most valuable altcoin at market peak. On-chain analytics firm Santiment noted a drop in small ADA wallets before the rally, suggesting a potential price turning point.

Portfolio Pulse from Khyathi Dalal

December 14, 2023 | 5:53 pm

NXTC

NextCure shares have declined following the company's release of year-end clinical pipeline updates.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 5:49 pm

BTCUSD

META

The article discusses the significant rise in Bitcoin's value since former President Donald Trump criticized it in 2019, stating it was 'based on thin air.' Bitcoin has recently surpassed $44,000, marking new 52-week highs. Trump, who has since launched three NFT collections, is among the 2024 presidential candidates, some of whom support cryptocurrency. An investment of $1,000 in Bitcoin at the time of Trump's tweet would now be worth $3,510.84, a 251.1% return. Meta Platforms Inc. (META) was also mentioned in relation to its virtual currency project, Libra.

Portfolio Pulse from Chris Katje

December 14, 2023 | 5:46 pm

CPTN

Cepton, Inc. (CPTN) and its partner Koito Manufacturing were previously selected as the sole lidar providers for a significant ADAS program through 2027. However, Koito has informed Cepton that the OEM has rescoped its ADAS offerings, leading to the cancellation of all outstanding purchase orders related to the series production award. Cepton plans to seek recovery of project investment costs and continues to work with the OEM on next-generation ADAS offerings. The collaboration with Koito and engagement with other OEMs is expected to continue.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 5:42 pm

NRSN

NeuroSense Therapeutics' stock is trading higher following the release of positive efficacy data from a Phase 2b trial of their lead drug candidate, PrimeC, for amyotrophic lateral sclerosis.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 5:41 pm

SNES

SenesTech shares have risen following the announcement of receiving 'substantial orders' for its EVOLVE Soft Bait product, indicating strong market demand and potential revenue growth.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 5:38 pm